✓ Last verified: April 3, 2026 — Edited & verified by Angelica Bottaro for HealingMaps Editorial Staff
Known For: The only Memphis-metro Spravato provider with integrated Intensive Outpatient Program (IOP) and Partial Hospitalization Program (PHP) wraparound — uniquely positioned for severe treatment-resistant depression patients who need more than standard medication management alongside their esketamine treatment.
| Review Scores | ⭐ Strong patient outcomes for treatment-resistant depression with co-occurring trauma/addiction |
| Location | Cordova, TN (East Memphis metro) |
| Address | 1088 Rogers Rd, Memphis, TN 38018 |
| Phone | (901) 755-1396 |
| Website | transformationmemphis.com |
| Treatments | Spravato (Esketamine) — REMS Certified, Spravato + IOP integration, Intensive Outpatient Program (IOP), Partial Hospitalization Program (PHP), Medication Management, Young Adults Program, “Intention Setting Hour”, DBT Skills, Mindfulness Activities |
| Conditions Treated | Treatment-Resistant Depression, Major Depressive Disorder with Suicidal Ideation, Trauma/PTSD, Anxiety, Mood Disorders, Personality Disorders, Psychotic Disorders, Eating Disorders, Substance Use Disorders (alcohol, cannabis, opioids, sedatives) |
| Cost | Contact for pricing |
| Insurance | Spravato in-network with every major insurance provider; insurance coordination handled in-house |
| KAP Available? | No — Spravato + IOP integration model with structured therapeutic programming (DBT skills, mindfulness, intention-setting) |
| Clinical Lead | Kristena Partridge, LCSW (Clinical Director); Nga Huynh, MD (Psychiatrist); Raj Mukatira, PhD, PMHNP (Psychiatric Nurse Practitioner) |
HealingMaps Take: The Transformation Center fills a clinical gap in the Memphis market that pure outpatient Spravato providers can’t address — patients whose treatment-resistant depression is severe enough to warrant IOP or PHP-level support but who also need access to FDA-approved esketamine therapy. Spravato can be delivered standalone or integrated with the structured IOP program (Mon-Fri 9-3 hours), where patients receive DBT skills training, mindfulness, “Intention Setting Hour” before treatments, and daily group/individual therapy. The clinical team — Dr. Nga Huynh (psychiatrist), Raj Mukatira PhD PMHNP (prescriber), and Kristena Partridge LCSW (clinical director) — gives the practice physician-level oversight that many Spravato-only clinics lack. Insurance coordination handled in-house removes the biggest barrier to Spravato access for working-class Memphis families. For TRD patients with co-occurring substance use, eating disorders, or trauma — populations that pure outpatient ketamine clinics often decline — Transformation Center’s full continuum of care (IOP/PHP/standalone Spravato) is uniquely equipped.
“The IOP integration is what made the difference for me. I’d done Spravato standalone at another clinic and the dissociation was scary because I had no framework. At Transformation Center, the Intention Setting Hour before each session, the DBT skills work, and the supportive group programming meant the medication had something to land on. My depression actually got better instead of just being temporarily blunted.”
The Transformation Center is a Spravato REMS-certified mental health and addiction treatment facility at 1088 Rogers Rd, Memphis, TN 38018, in the Cordova / East Memphis area. The practice offers Spravato (esketamine) nasal spray for treatment-resistant depression both standalone and as part of an integrated Intensive Outpatient Program. The IOP/PHP framework wraps Spravato with structured therapeutic programming including DBT skills training, mindfulness practices, “Intention Setting Hour” pre-session work, group and individual therapy, and medication management. Spravato dosing follows the FDA induction protocol: twice weekly for 4 weeks, weekly for 4 weeks, then maintenance at weekly or bi-weekly intervals.
Clinical leadership includes Dr. Nga Huynh, MD (psychiatrist), Raj Mukatira, PhD, PMHNP (psychiatric nurse practitioner and prescriber), and Kristena Partridge, LCSW (Clinical Director). The practice treats treatment-resistant depression, major depressive disorder with suicidal ideation, trauma and PTSD, anxiety disorders, mood disorders, personality disorders, psychotic disorders, eating disorders, and substance use disorders (alcohol, cannabis, opioids, sedatives, illicit drugs). Hours: Monday-Thursday 9:00 AM to 5:00 PM, Friday 9:00 AM to 3:00 PM. Spravato medication is in-network with every major insurance provider, and insurance coordination is handled by the clinic.
For more on how Spravato (esketamine) works for treatment-resistant depression, see our guide to IV ketamine vs. Spravato.
This 4-question summary is matched to the protocols and conditions Transformation Center (Spravato IOP Program) treats. Editorial responses are HealingMaps-authored, grounded in our 2026 Ketamine Clinic Intelligence Report.
Yes — Transformation Center (Spravato IOP Program) offers Spravato, which means they’re FDA REMS-certified and maintain the required two-hour in-office monitoring window after each dose. Spravato is the primary insurance-covered ketamine option for treatment-resistant depression. Worth confirming the prior-authorization timeline before booking your first session.
Transformation Center (Spravato IOP Program) treats depression via Spravato (FDA-approved for TRD). The Spravato pathway is the most likely to obtain commercial insurance coverage. TRD is typically defined as two or more prior antidepressant trials without sufficient response — patients meeting that bar are best candidates here.
Yes — Transformation Center (Spravato IOP Program) treats PTSD. Spravato can be used for trauma. Ketamine for trauma differs from depression treatment: dosing is often lower per session, and pairing the protocol with trauma-focused therapy between sessions is common. A reasonable consult question: whether PTSD patients here typically use ketamine alone or alongside an outside therapist.
Yes — Transformation Center (Spravato IOP Program) treats anxiety, including generalized anxiety, social anxiety, and panic disorder. The evidence base for ketamine in anxiety is less robust than for depression, but it can be a meaningful option for patients who haven’t responded to SSRIs or benzodiazepines. Worth asking which of their protocols they typically recommend for anxiety-primary patients.
Leave a Reply